PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma

Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients,...

Full description

Saved in:
Bibliographic Details
Published in:Egyptian journal of radiology and nuclear medicine Vol. 51; no. 1; pp. 213 - 17
Main Authors: Zytoon, Ashraf Anas, Mohamed, Hala Hafez, Mostafa, Basma Adel Abd Elaziz, Houseni, Mohamed Mohamed
Format: Journal Article
Language:English
Published: Cairo Springer 23-10-2020
Springer Nature B.V
SpringerOpen
Subjects:
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Abstract Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. Results 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. Conclusion 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens.
AbstractList Abstract Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. Results 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. Conclusion 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens.
Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Methods Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. Results 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. Conclusion 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens.
The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma. Hundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared. 18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients. 18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens.
BackgroundThe aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography (18 F-FDG PET/CT) in assessment of lymphoma.MethodsHundred patients, pathologically proven as lymphoma, were evaluated by CECT and 18F-FDG PET/CT for initial assessment and staging of the disease. The number of lesions and the disease stage detected by each modality was calculated and further analyzed to be compared.Results18F-FDG PET/CT diagnosed a total number of 545 lymphoma involved regions with sensitivity 96.6%, specificity 98.8%, and accuracy 99% that was higher than CECT which diagnosed a total number of 439 lymphomatous regions with sensitivity 87.5%, specificity 85.7%, and accuracy 88%. Discordant staging by both modalities was found in 23% of the patients. Lymphoma was upstaged by PET/CT in 17% of the patients; with major changes in 12% of them and downstaged in 6% of the patients.Conclusion18F-FDG PET/CT scan has a better diagnostic performance, represented by sensitivity, specificity, and accuracy, than CECT scan in the initial assessment of lymphoma regarding its nodal and extra-nodal lesions that could lead to alteration of disease staging which in turn markedly affecting the decision of treatment regimens.
Audience Professional
Academic
Author Zytoon, Ashraf Anas
Houseni, Mohamed Mohamed
Mohamed, Hala Hafez
Mostafa, Basma Adel Abd Elaziz
Author_xml – sequence: 1
  fullname: Zytoon, Ashraf Anas
– sequence: 2
  fullname: Mohamed, Hala Hafez
– sequence: 3
  fullname: Mostafa, Basma Adel Abd Elaziz
– sequence: 4
  fullname: Houseni, Mohamed Mohamed
BookMark eNptUE1LJDEQDeKCo-sf8BTYc2u-k96bDOoKgh5mYW9NdT5mMk4ns53I4r836oIerIIqePXeo3jH6DDl5BE6o-ScUqMuiuBEyo4w0hHCX-cBWjDSk05oxQ7RgnBtOkX4nyN0WsqWtBKEUCUWaPNwtbpYrjAkh21OdYZSO582kKx3eLn6iSd4jGmNAbsYgp99O-CYMJTiS5l8qm_aUmH9SssB76HGBhf8L9YN3j1P-02e4Dv6FmBX_On_fYJ-X1-tlr-6u_ub2-XlXWdFr2rHXJCj65UWmknLHCNchlHLfiTcCgrOKToqKrVXejTWgvFeKO6CBm2EJvwE3b77ugzbYT_HCebnIUMc3oA8rweYa7Q7P1AqjeyVsTAaIQI3jhnHteNCCWAsNK8f7177Of998qUO2_w0p_b-wAxlytC-lx-sNTTTmEJuKdopFjtcKkOoNkb1jXX-Bau181NsyfsQG_5J8ALTJI-B
CitedBy_id crossref_primary_10_3390_hemato2040041
crossref_primary_10_1155_2022_4736455
crossref_primary_10_4236_ojmi_2021_112005
crossref_primary_10_1016_j_ejro_2024_100566
ContentType Journal Article
Copyright COPYRIGHT 2020 Springer
The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
Copyright_xml – notice: COPYRIGHT 2020 Springer
– notice: The Author(s) 2020. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.
DBID 3V.
7X7
7XB
8FI
8FJ
8FK
ABUWG
AFKRA
AZQEC
BENPR
CCPQU
DWQXO
FYUFA
GHDGH
K9.
M0S
PIMPY
PQEST
PQQKQ
PQUKI
PRINS
DOA
DOI 10.1186/s43055-020-00320-0
DatabaseName ProQuest Central (Corporate)
Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
ProQuest Central Essentials
ProQuest Central
ProQuest One Community College
ProQuest Central Korea
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
Publicly Available Content Database
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
ProQuest Central China
DOAJ Directory of Open Access Journals
DatabaseTitle Publicly Available Content Database
ProQuest Central Essentials
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Central China
ProQuest Hospital Collection (Alumni)
ProQuest Central
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
ProQuest Central Korea
ProQuest One Academic
ProQuest Central (Alumni)
DatabaseTitleList


Publicly Available Content Database
Database_xml – sequence: 1
  dbid: DOA
  name: Directory of Open Access Journals
  url: http://www.doaj.org/
  sourceTypes: Open Website
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 2090-4762
EndPage 17
ExternalDocumentID oai_doaj_org_article_11585968cab844f38d28d37d3464a22f
A680178869
GeographicLocations Egypt
United States--US
GeographicLocations_xml – name: Egypt
– name: United States--US
GroupedDBID ---
--K
0R~
0SF
4.4
457
6I.
7X7
8FI
8FJ
AACTN
AAEDT
AAFWJ
AAIKJ
AAKKN
AAYZJ
ABEEZ
ABMAC
ABUWG
ACACY
ACGFS
ACULB
ADBBV
ADEZE
AFGXO
AFKRA
AFPKN
AGHFR
AHBXF
AKRWK
ALMA_UNASSIGNED_HOLDINGS
BAWUL
BCNDV
BENPR
C24
C6C
CCPQU
DIK
E3Z
EBS
FDB
FYUFA
GROUPED_DOAJ
HMCUK
IAO
IHR
INH
ITC
IXB
KQ8
O-L
O9-
OK1
PIMPY
RSV
SES
SOJ
UKHRP
XH2
3V.
7XB
8FK
AZQEC
DWQXO
K9.
PQEST
PQQKQ
PQUKI
PRINS
ID FETCH-LOGICAL-c496t-2df5bd9674725c2d2035fb759b03c41add61b6157e67b8cca8ee463df7a784703
IEDL.DBID DOA
ISSN 0378-603X
IngestDate Tue Oct 22 15:15:59 EDT 2024
Thu Oct 10 20:37:48 EDT 2024
Tue Nov 19 21:09:56 EST 2024
Tue Nov 12 22:46:19 EST 2024
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 1
Language English
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c496t-2df5bd9674725c2d2035fb759b03c41add61b6157e67b8cca8ee463df7a784703
OpenAccessLink https://doaj.org/article/11585968cab844f38d28d37d3464a22f
PQID 2812681995
PQPubID 5758466
PageCount 17
ParticipantIDs doaj_primary_oai_doaj_org_article_11585968cab844f38d28d37d3464a22f
proquest_journals_2812681995
gale_infotracmisc_A680178869
gale_infotracacademiconefile_A680178869
PublicationCentury 2000
PublicationDate 2020-10-23
PublicationDateYYYYMMDD 2020-10-23
PublicationDate_xml – month: 10
  year: 2020
  text: 2020-10-23
  day: 23
PublicationDecade 2020
PublicationPlace Cairo
PublicationPlace_xml – name: Cairo
PublicationTitle Egyptian journal of radiology and nuclear medicine
PublicationYear 2020
Publisher Springer
Springer Nature B.V
SpringerOpen
Publisher_xml – name: Springer
– name: Springer Nature B.V
– name: SpringerOpen
SSID ssj0000400164
Score 2.2245266
Snippet Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18]...
The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18] fluoro-2-deoxy-d-glucose...
BackgroundThe aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18]...
Abstract Background The aim of this study is to evaluate the diagnostic performance of contrast-enhanced computed tomography (CECT) and 2-[Fluorine-18]...
SourceID doaj
proquest
gale
SourceType Open Website
Aggregation Database
StartPage 213
SubjectTerms 18F-FDG PET/CT: 2-[Fluorine-18] fluoro-2-deoxy-d-glucose positron emission tomography combined to computed tomography
Bone marrow
CECT: contrast-enhanced computed tomography
CT imaging
Dextrose
Diabetes
Diagnosis
Disease
Fluorides
Glucose
Insulin
Lymphoma
Medical imaging
Metabolism
Non-Hodgkin's lymphomas
Patients
PET imaging
Radiation
Tomography
Tumors
Title PET/CT and contrast-enhanced CT: making a difference in assessment and staging of patients with lymphoma
URI https://www.proquest.com/docview/2812681995
https://doaj.org/article/11585968cab844f38d28d37d3464a22f
Volume 51
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://sdu.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1LSwMxEA7WkxdRVKzWkoPgKTRNsnl4q7XiSQQreFuSTYKC3YrbHvz3TrJboQfx4nU3C8PMZB7ZyfchdGlMOq6JnFATIhFjyon2Y2hcZQXewayyLp133D-phxd9O0swOT9UX2kmrIUHbhU3gopFF0bqyjotROTaM-258lxIYRmLOfpS2TZTm1sxWo6ajGVFUndEE0k4oR0q_2-xNyeUuwO031WCeNJKcIh2Qn2EXh9n89F0jqG_x3mK3DYrEurX_J8eT-fXeJHpo7DFG2qTKuC3GtsfhM38LdR8iX0ILyPukFMbnI5c8fsXmG-5sMfo-W42n96TjgyBVMLIFWE-Fs4bCeU_KyrmGeVFdKowjvJKjCFMybGD8kQFqZwGu-gQhOQ-KqsgA1F-gnbrZR1OEVZpNRXcecYFxGprbBGp1U4UlFvH-ugmKar8aPEuyoRAnR-AXcrOLuVfdumjq6TmMu0TUFZlu3F_ECEhTpUTCbkR-m9p-miwtRL8u9p-vTFU2e2vpmRQl0idrpef_Yew52iPJU-BnMT4AO2uPtfhAvUavx6i3pSJYfaub-sP0W8
link.rule.ids 315,782,786,866,2106,27933,27934
linkProvider Directory of Open Access Journals
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=PET%2FCT+and+contrast-enhanced+CT%3A+making+a+difference+in+assessment+and+staging+of+patients+with+lymphoma&rft.jtitle=Egyptian+journal+of+radiology+and+nuclear+medicine&rft.au=Zytoon%2C+Ashraf+Anas&rft.au=Mohamed%2C+Hala+Hafez&rft.au=Mostafa%2C+Basma+Adel+Abd+Elaziz&rft.au=Houseni%2C+Mohamed+Mohamed&rft.date=2020-10-23&rft.pub=Springer+Nature+B.V&rft.issn=0378-603X&rft.eissn=2090-4762&rft.volume=51&rft.issue=1&rft.spage=213&rft_id=info:doi/10.1186%2Fs43055-020-00320-0&rft.externalDBID=HAS_PDF_LINK
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0378-603X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0378-603X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0378-603X&client=summon